ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $629,000 | +7.7% | 430,708 | +4.8% | 0.00% | +50.0% |
Q4 2016 | $584,000 | -17.9% | 410,946 | +1.2% | 0.00% | -33.3% |
Q3 2016 | $711,000 | +158.5% | 406,211 | +152.3% | 0.00% | +200.0% |
Q2 2016 | $275,000 | -13.2% | 161,031 | +5.5% | 0.00% | 0.0% |
Q1 2016 | $317,000 | +4.6% | 152,604 | -4.2% | 0.00% | 0.0% |
Q4 2015 | $303,000 | +1.0% | 159,227 | +1.5% | 0.00% | 0.0% |
Q3 2015 | $300,000 | -58.8% | 156,944 | 0.0% | 0.00% | -66.7% |
Q2 2015 | $728,000 | -5.8% | 156,944 | -11.2% | 0.00% | 0.0% |
Q1 2015 | $773,000 | +32.8% | 176,790 | +5.3% | 0.00% | +50.0% |
Q4 2014 | $582,000 | -17.9% | 167,813 | -0.8% | 0.00% | -33.3% |
Q3 2014 | $709,000 | -28.5% | 169,226 | +0.0% | 0.00% | -25.0% |
Q2 2014 | $991,000 | +0.5% | 169,193 | +0.4% | 0.00% | 0.0% |
Q4 2013 | $986,000 | +8.0% | 168,497 | -2.7% | 0.00% | 0.0% |
Q3 2013 | $913,000 | -28.1% | 173,154 | +5.0% | 0.00% | -42.9% |
Q2 2013 | $1,270,000 | – | 164,892 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
GAM Holding AG | 523,164 | $997,000 | 0.02% |
STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |